2FENECK R. Drugs for the perioperative control of hyperten- sion:current issues and future directions [J]. Drugs, 2007, 67 (14) :2023-2044.
3Fan Z, Si L, Xu L, et al. Determination of TJ0711 hydrochlo ride in rat plasma by high performance liquid chromatography with fluorescence detection and its application to pharmacoki- netics[J]. Chromatogr B Analyt Technol Biomed Life Sci, 2010 Jul 15; 878(22) :2035-8.
4Hamlyn JM, Blaustein MP. Salt sensitivity, endogenous oua bain and hypertension [J]. Curt Opin Nephrol Hypertens. 2013, 22(1): 51-58.
5Padilha AS1, Salaices M, Vassallo DV, et al. Hypertensive effects of the iv administration of picomoles of ouabain[J]. Brazilian Journal of Medical and Biological Research. 2011, 44: 933-938.
7R. R. Ruffolo Jr, M. Gellai, J. R Hieble, etal. The phar maeology of carvedilol[J]. Eur J Clin Pharmacol, 1990, 38: 882-888.
8Susan F. Lien & John D. Bisognano,Perioperative Hyperten- sion: Defining At Risk Patients and Their Management [J]. Curr Hypertens Rep, 2012, 14:432-441.
